Make sure you attend the Partner Presentation during the AAPS PharmaSci 360 – 5 November, 10.30 h – Solution Center.
Preclinical TIM technology vs in vivo performance of oral drug products
TIM simulates human gastrointestinal conditions of the human and is used to study the performance of oral drug candidates. Because of it’s high predictivity for the human situation, it supports the preclinical drug development process, the choice for further testing and ultimately contributes to de-risking clinical trials. Our partners from AstraZeneca will highlight practical and day to day applications examples and zoom in on several specific technical features of TIM.
We are looking forward to meet you there.